rs199473453
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3PP5
The NM_000218.3(KCNQ1):c.478G>A(p.Glu160Lys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 15/25 in silico tools predict a damaging outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E160V) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.478G>A | p.Glu160Lys | missense_variant, splice_region_variant | 3/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.478G>A | p.Glu160Lys | missense_variant, splice_region_variant | 3/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.97G>A | p.Glu33Lys | missense_variant, splice_region_variant | 3/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.217G>A | p.Glu73Lys | missense_variant, splice_region_variant | 4/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.478-12807G>A | intron_variant | ENSP00000495806 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 19, 2019 | The p.E160K variant (also known as c.478G>A) is located in coding exon 3 of the KCNQ1 gene. The glutamic acid at codon 160 is replaced by lysine, an amino acid with similar properties. This change occurs in the first base pair of coding exon 3. This alteration has been reported in several long QT syndrome (LQTS) cohorts with limited clinical information (Splawski I et al. Circulation. 2000;102:1178-85; Tester DJ et al. Heart Rhythm. 2005;2:507-17; Moss AJ et al. Circulation. 2007;115:2481-9). Multiple functional studies indicate this variant significantly reduces peak potassium current density, though two of the studies disagree on whether this alteration results in a trafficking defect (Silva JR et al. Proc. Natl. Acad. Sci. U.S.A. 2009;106:11102-6; Wu D et al. J. Gen. Physiol. 2010;135:595-606; Bartos DC et al. Heart Rhythm. 2011;8:48-55; Vanoye C et al. 2017. https://www.biorxiv.org/content/early/2017/11/21/223206; Huang H et al. Sci Adv, 2018;4:eaar2631). Internal structural analysis indicates that this variant interacts with residues of known function and is more disruptive than known pathogenic variants in the region (Ambry internal data; Berman HM et al. Acta Crystallogr. D Biol. Crystallogr. 2002;58:899-907). Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to slightly weaken the efficiency of the native splice acceptor site; however, direct evidence is unavailable. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 29532034, 30571187). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 53049). This missense change has been observed in individual(s) with long QT syndrome (PMID: 10973849, 22949429, 30571187). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 160 of the KCNQ1 protein (p.Glu160Lys). - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:10973849;PMID:15840476;PMID:19841300;PMID:17470695). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at